Multi-omic platform for identifying causal and druggable alzheimer's disease targets
Multi-tissue multi-omic profiling platform combining genomics, transcriptomics, proteomics, metabolomics, and lipidomics to identify causal genes, molecular biomarkers, and drug targets for Alzheimer's disease. Includes ...